With regard to the role of RasGRF2 in carcinogenesis and cancer progression, aberrant methylation and reduced expression of RasGRF2 have recently been observed in non‐small cell lung cancers,4 mammary carcinomas5 and benign colorectal adenomas.6 This evidence concerns the gene RASGRF2 and lung cancer.